Hookipa Biotech scores $59.6 mln Series C
Hookipa Biotech AG, an Austrian clinical stage biotech company, has raised $59.6 million in Series C financing. The investors included HBM Partners, Hillhouse Capital, Sirona Capital, Gilead, Sofinnova Partners, Forbion Capital Partners, Boehringer Ingelheim Venture Fund, Takeda Ventures and BioMedPartners.
11 December 2017•1 min read
